Celcuity Inc (CELC) PT Lowered to $145 at H.C. Wainwright Jun 3, 2026 06:50AM
Guggenheim Reiterates Buy Rating on Celcuity Inc (CELC) Jun 3, 2026 06:38AM
Celcuity Inc (CELC) PT Lowered to $166 at Wells Fargo Jun 3, 2026 05:28AM
Celcuity (CELC) Reiterated at Market Outperform by Citizens Jun 3, 2026 04:33AM
Celcuity Inc (CELC) PT Lowered to $155 at Leerink, 'we expect CELC shares to be under pressure given the lofty expectations' Jun 2, 2026 09:21AM
View Older Stories

Jun 2, 2026 08:51AM Stifel on Celcuity Inc (CELC) Amid 20% Selloff: 'We remain confident in PIK3CA-WT regulatory prospects'
Jun 2, 2026 08:11AM Celcuity reports positive Phase 3 trial results for gedatolisib in breast cancer
May 28, 2026 05:56AM Celcuity (CELC) Reiterated at Market Outperform by Citizens Ahead of ASCO Presentation
May 18, 2026 07:21AM Celcuity (CELC) Reiterated at Market Outperform by Citizens Ahead of ASCO Data
May 18, 2026 07:05AM Celcuity Inc (CELC) PT Raised to $185 at H.C. Wainwright
May 15, 2026 09:20AM Celcuity Inc (CELC) PT Raised to $175 at Stifel
May 14, 2026 04:02PM Celcuity (CELC) Tops Q1 EPS by 7c
May 4, 2026 02:09PM Celcuity (CELC) call put ratio 1 call to 2.5 puts with a focus on May puts as share price up 16%
May 4, 2026 10:13AM Increasing unusual option volume: TPG XRX FXY CGNX MRAM CRNC CELC SIMO
May 4, 2026 10:01AM Celcuity Inc (CELC) PT Raised to $160 at Citizens
May 4, 2026 07:24AM Celcuity Inc (CELC) PT Raised to $165 at Guggenheim
May 4, 2026 07:21AM Celcuity Inc (CELC) PT Raised to $157 at Needham
May 4, 2026 06:59AM Celcuity Inc (CELC) PT Raised to $150 at Stifel on PIK3CA Data
May 4, 2026 06:14AM H.C. Wainwright Upgrades Celcuity Inc (CELC) to Buy
Apr 27, 2026 01:58AM Citizens Starts Celcuity Inc (CELC) at Market Outperform
Mar 27, 2026 06:47AM H.C. Wainwright Reiterates Neutral Rating on Celcuity Inc (CELC)
Mar 26, 2026 10:58AM Celcuity Inc (CELC) PT Raised to $141 at Craig-Hallum
Mar 26, 2026 07:13AM Celcuity Inc (CELC) PT Raised to $125 at Stifel on Reduced OpEx Estimates
Mar 25, 2026 04:01PM Celcuity (CELC) Tops Q4 EPS by 32c
Mar 12, 2026 09:58AM Wolfe Research Reiterates Outperform Rating on Celcuity Inc (CELC): "Relay's update does not appear to change the efficacy benchmark"
Mar 10, 2026 07:08AM Celcuity Inc (CELC) PT Raised to $122 at Needham
Mar 2, 2026 02:39PM Celcuity (CELC) 5K contracts of April 130 calls trade
Feb 4, 2026 09:58AM Wolfe Research: 'We'd be buyers of CELC on any weakness related to the external catalyst'
Jan 20, 2026 07:30AM Celcuity receives FDA acceptance for gedatolisib breast cancer drug
Dec 23, 2025 05:30PM Jefferies lists 5 biotech M&A candidates for 2026
Dec 17, 2025 04:02AM Celcuity Inc (CELC) PT Raised to $118 at Leerink Partners
Dec 12, 2025 05:22AM Wells Fargo Starts Celcuity Inc (CELC) at Overweight
Dec 1, 2025 05:10PM Celcuity Inc (CELC) PT Raised to $134 at Jefferies
Nov 25, 2025 11:15AM Jefferies on Celcuity Inc (CELC): 'we believe everolimus+gire could be a good option specifically for the PIK3CAwt/ESR1mut subgrp'
Nov 18, 2025 11:50AM Increasing unusual call option volume: EQG CELC BBD FE CWAN
Nov 17, 2025 04:11PM Wolfe Research Starts Celcuity Inc (CELC) at Outperform
Nov 17, 2025 06:23AM H.C. Wainwright Downgrades Celcuity Inc (CELC) to Neutral
Nov 13, 2025 04:45AM Celcuity Inc (CELC) PT Raised to $115 at Stifel
Nov 12, 2025 04:13PM Celcuity (CELC) Tops Q3 EPS by 10c
Oct 30, 2025 10:41AM Increasing unusual call option volume: BBD BORR APLS VIAV ROIV FMC VITL RSI METU OWL FBL FI CELC
Sep 22, 2025 02:23AM Guggenheim Starts Celcuity Inc (CELC) at Buy
Sep 9, 2025 04:01PM Celcuity increases term loan facility to $500 million
Aug 18, 2025 06:47AM Celcuity Inc (CELC) PT Raised to $66 at H.C. Wainwright
Aug 15, 2025 11:47AM Celcuity Inc (CELC) PT Raised to $68 at Stifel
Aug 15, 2025 07:08AM Celcuity Inc (CELC) PT Lowered to $70 at Needham
Aug 15, 2025 05:08AM Celcuity Inc (CELC) PT Raised to $79 at Jefferies
Aug 14, 2025 04:02PM Celcuity (CELC) Misses Q2 EPS by 16c
Jul 29, 2025 06:41AM Celcuity Inc (CELC) PT Raised to $50 at H.C. Wainwright
Jul 14, 2025 07:06AM Celcuity receives patent extending gedatolisib exclusivity to 2042
Jul 1, 2025 05:18AM Stifel Assumes Celcuity (CELC) at Buy
Jun 30, 2025 07:05AM Celcuity (CELC) Reports Clinical Data from Two Early Phase Studies of Gedatolisib
May 14, 2025 04:04PM Celcuity (CELC) Misses Q1 EPS by 14c
Apr 1, 2025 09:16AM Stifel Reiterates Buy Rating on Celcuity Inc (CELC)
Mar 31, 2025 04:01PM Celcuity (CELC) Misses Q4 EPS by 4c
Jan 23, 2025 07:27AM Celcuity Inc (CELC) PT Raised to $33 at Jefferies
View Older Stories